Results 21 to 30 of about 194,896 (346)

4′-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication

Science, 2021
Description Preparing antiviral defenses Antiviral drugs are an important tool in the battle against COVID-19. Both remdesivir and molnupiravir, which target the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) polymerase, were first ...
Julien Sourimant, C. Lieber, Megha Aggarwal, R. Cox, J. Wolf, Jeong-Joong Yoon, M. Toots, Chengin Ye, Zachary M. Sticher, A. Kolykhalov, L. Martínez-Sobrido, Gregory R. Bluemling, M. Natchus, G. Painter, Richard K. Plemper   +14 more
semanticscholar   +1 more source

Prevalence of human respiratory syncytial virus, parainfluenza and adenoviruses in East Africa Community partner states of Kenya, Tanzania, and Uganda: A systematic review and meta-analysis (2007-2020).

PLoS ONE, 2021
BackgroundViruses are responsible for a large proportion of acute respiratory tract infections (ARTIs). Human influenza, parainfluenza, respiratory-syncytial-virus, and adenoviruses are among the leading cause of ARTIs.
Therese Umuhoza, Wallace D Bulimo, Julius Oyugi, Jean Pierre Musabyimana, Alison A Kinengyere, James D Mancuso   +5 more
doaj   +1 more source

RESPIRATORY SYNCYTIAL AND OTHER VIRUSES ASSOCIATED WITH RESPIRATORY DISEASE IN INFANTS [PDF]

The Lancet, 1971
Diagnosis by virus isolation and serology was attempted in 377 cases of respiratory-tract infection in infants under one year of age admitted to hospital during two winters. A diagnosis of infection with respiratory syncytial (R.S.) virus was made in 40%, rhinovirus in 6·1%, adenovirus in 3·7%, parainfluenza in 2·1%, enterovirus in 1·9%, and influenza ...
Jacobs, J.W., Peacock, D.B., Corner, B.D., Caul, E.O., Clarke, S.K.R.   +4 more
openaire   +2 more sources

Respiratory virus infections in hospitalized and non-hospitalized children: determinants of severe course of the disease

Journal of Infection in Developing Countries, 2022
Introduction: Viral respiratory disease constitutes a great burden worldwide mainly among children. Objective: One pursued to compare disease characteristics of children who required hospitalization from those who did not require hospitalization due to ...
Lourenço Faria Costa, Hélio Lopes da Silveira, Divina Aparecida Oliveira Queiróz, Orlando Cesar Mantese, Jonny Yokosawa   +4 more
doaj   +1 more source

Genetic Variation and Disease Severity of Respiratory Syncytial Viruses [PDF]

, 2022
AbstractRespiratory Syncytial Virus (RSV) disease in newborns ranges from mild symptoms to severe disease requiring hospitalization. RSV is classified into two subtypes (RSVA and RSVB) based on antigenic and genetic differences. The role these genomic variations play in disease severity remains unknown.
Christopher S. Anderson, Yun Zhang, Anthony Corbett, Chinyi Chu, Alexander Grier, Lu Wang, Xing Qiu, Mathew Mccall, David J. Topham, Edward E. Walsh, Thomas J. Mariani, Richard Scheuermann, Mary T. Caserta   +12 more
openaire   +1 more source

Evaluation of Severe Acute Respiratory Syndrome surveillance caused by respiratory viruses in a pediatric unit, 2013 to 2019

Revista Paulista de Pediatria, 2023
Objective: To evaluate severe acute respiratory syndrome surveillance in a pediatric unit. Methods: Descriptive study of reported severe acute respiratory syndrome cases with the detection of respiratory viruses in the nasopharyngeal sample of patients ...
Felipe Teixeira de Mello Freitas, Cíntia Costa Pereira Pimentel, Pedro Ribeiro Bianchini, Rafaela Moreira de Carvalho, Alexandre Peixoto Serafim, Cira Ferreira Antunes Costa   +5 more
doaj   +1 more source

Burden of influenza, respiratory syncytial virus, and other respiratory viruses and the completeness of respiratory viral identification among respiratory inpatients, Canada, 2003‐2014

Influenza and Other Respiratory Viruses, 2017
A regression‐based study design has commonly been used to estimate the influenza burden; however, these estimates are not timely and many countries lack sufficient virological data.
D. Schanzer, M. Saboui, L. Lee, Andrea Nwosu, C. Bancej   +4 more
semanticscholar   +1 more source

Current practices for treatment of respiratory syncytial virus and other non‐influenza respiratory viruses in high‐risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative

Transplant Infectious Disease, 2016
The optimal treatment for respiratory syncytial virus (RSV) infection in adult immunocompromised patients is unknown. We assessed the management of RSV and other non‐influenza respiratory viruses in Midwestern transplant centers.
O. Beaird, Allison Freifeld, Michael G. Ison, Steven J. Lawrence, Nicole Theodoropoulos, Nina M. Clark, R. Razonable, G. Alangaden, Rachel Miller, J. Smith, Jo Anne H. Young, Dana J. Hawkinson, Kenneth Pursell, Daniel R. Kaul   +13 more
semanticscholar   +1 more source

Study of the Mechanism of Antiviral Activity of Cytovir®-3 Against Respiratory Viruses In Vitro

Антибиотики и Химиотерапия, 2023
Introduction. The requirements of modern clinical guidelines for the treatment of respiratory viral infections suggest the possibility of identifying a specific viral pathogen.
V. V. Zarubaev, V. S. Smirnov, T. A. Kudryavtseva, S. V. Petlenko, A. V. Slita, H. Minh, V. A. Zaplutanov   +6 more
doaj   +1 more source

Where have all the viruses gone? Disappearance of seasonal respiratory viruses during the COVID‐19 pandemic

Journal of Medical Virology, 2021
Many viruses cause seasonal respiratory infections in temperate climates that peak in the winter months. They cause varying degrees of respiratory illness across all age groups, and include respiratory syncytial virus (RSV), parainfluenza viruses (types ...
J. Tang, S. Bialasiewicz, D. Dwyer, M. Dilcher, R. Tellier, Janette Taylor, Harry Hua, L. Jennings, J. Kok, A. Levy, David W Smith, I. Barr, S. Sullivan   +12 more
semanticscholar   +1 more source